Pharmacokinetics of chloramphenicol (CAP) in gilthead sea bream (Sparus aurata) and its in vitro activities against important bacterial fish pathogens


Published: Dec 19, 2017
Keywords:
Pharmacokinetics chloramphenicol MIC seabream
A. E. TYRPENOU (Α.Ε. ΤΥΡΠΕΝΟΥ)
G. RIGOS (Γ. ΡΗΓΟΣ)
M. YAGNISI (Μ. ΓΙΑΓΝΙΣΗ)
I. NENGAS (Ι. ΝΕΓΚΑΣ)
M. ALEXIS (Μ. ΑΛΕΞΗΣ)
Abstract

The pharmacokinetics of chloramphenicol (CAP) in gilthead sea bream (Sparus aurata), a warm water farmed fish species and its in vitro efficacy against important bacterial diseases of Mediterranean mariculture were investigated in this study. After an intravascular injection (10 mg/kg/fish), the distribution half-life (tl/2a) and the elimination half-life (tl/2ß) of CAP were calculated to be 1.6 and 69 h, respectively. Tissue penetration of CAP was found to be moderate since both the apparent volume of distribution of the drug at steady-state (V<i(ss)) and the apparent volume of the central compartment (Vc) were calculated to be 1.13 and 0.90 L/kg. The total clearance (CLp) of the drug was slow (0.022 L/kg/h). The minimum inhibitory concentration (MIC) values of CAP in distilled water supplemented with 2% NaCl against Vibrio anguillarum serotype lb, Photobacterium damsela subsp. piscicida, V alginolyticus and V ßuvialis were determined to be 4.78 pg/mL, while it was 0.60 pg/mL for V. damsela. The addition of 10 mM Ca2+ and 55 mM Mg2+ in the medium revealed MIC values of 19.13 pg/mL for V alginolyticus and V ßuvialis, whereas showed no effect for V anguillarum P. damsela subsp. Piscicida and V damsela. The results indicate that CAP displayed a satisfactory kinetic profile and it is eliminated fast from gilthead sea bream muscle; however, its high MIC values stress show a possible inefficacy against important bacterial pathogens of Mediterranean mariculture.

Article Details
  • Section
  • Research Articles
Downloads
Download data is not yet available.
References
Anhalt G (1977) Residues of antibiotics in freshwater fish. Neue Folge, 55:848-854
Baggot JD (1977) The Principles of Drug Disposition in Domestic Animals. In: The basis of Veterinary Clinical Pharmacology. W.B. Saunders Co., Philadelphia, pp. 238
Bakopoulos V, Adams A, Richards RH (1995) Some biochemical properties and antibiotic sensitivities of Pasteurella piscicida isolated in Greece in comparison with strains from Japan, France and Italy. Journal of Fish Diseases, 18:1-7
Barnes AC, Hastings TS, Amyes SGB (1995) Aquaculture antibacterials are antagonized by seawater cations. Journal of Fish Diseases, 18:463-465
Cravedi JP, Heuillet JC, Wal JM (1985) Disposition and metabolism of chloramphenicol in trout. Xenobiotica, 15:115-121
I ARC 1990 International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Pharmaceutical Drugs,Vol. 50. Lyon, France, pp. 415
Ishida Ν (1992) Tissue levels of oxolinic acid after oral or intravascular administration in freshwater and seawater rainbow trout. Aquaculture, 102:9-15
Liu CK, Liu YF (1993) Distribution and residues of chloramphenicol in prawns. CO A Fisheries Series, 48:10-16
Lunestad BT, Samuelsen OB (2001) Effects of sea water on the activity of antimicrobial agents used in aquaculture; implications for MIC testing. Aquaculture, 196:319-323
Mercedes A, Blanch AR (1994) A set of keys for biochemical identification of environmental Vibrio species. Journal of Applied Bacteriology, 76:79-85
MVM (1998) The Merck Veterinary Manual. S.E. Aiello and A. Mays, eds. Whitehouse Station, NJ: 1775-1779
Pursell L, Samuelsen OB, Smith Ρ (1995) Reduction in the in-vitro activity of flumequine against Aeromonas salmonicida in the presence of the concentrations of Mg2+ and Ca2+ ions found in seawater. Aquaculture, 135:245-255
Rigos G, Alexis M, Tyrpenou AE, Nengas I, Piper I, Troisi G (2002) Pharmacokinetics of oxolinic acid in gilthead sea bream, Spams aurata L. Journal of Fish Diseases, 25:1-8.
Rigos G, Tyrpenou AE, Nengas I, Yiagnisi M, Koutsodimou M, Alexis M, Troisi G (2003α) Evaluation of flumequine as a treatment agent in Mediterranean mariculture; pharmacokinetics in gilthead sea bream Spams aurata and in vitro activity against important bacterial fish pathogens. Diseases of Aquatic Organisms, 54:35-41
Rigos G, Nengas I, Tyrpenou AE, Alexis M, Troisi G (2003b) Pharmacokinetics of Oxytetracycline in gilthead sea bream, Spams aurata L. Aquaculture, 221:75-83
Ritschel WA (1986) Handbook of Basic Pharmacokinetics including clinical applications. 3rd ed, Drug Intelligence Publications Inc., Hamilton, pp. 544
Robert R, Miner P, Nicolas JL (1996) Mortality control of scallop larvae in the hatchery. Aquaculture International, 4:305-313
Skare JU, Hastein T, Froslie A (1974) Determination of residues of chloramphenicol in rainbow trout (Salmo gairdneri) and Atlantic salmon (Salmo salar). Nord Veterinary Medicine, 26:108-115
Smith P, Hiney M, Samuelsen OB (1994) Bacterial resistance to antimicrobial agents used in fish farming; a critical evaluation on method and meaning. Annual Review of Fish Diseases, 4:273-313
Stamm JM (1989) In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and sarafloxacin (A-56620). Journal of Aquatic Animal Health, 1:135-141
Stegeman JJ (1989) Cytochrome P-450 forms in fish: catalytic, immunological and sequence similarities. Xenobiotica, 19:1093-1110
Torkildsen L, Samuelsen OB, Lunestad, BT, Bergh, Ο (2000) Minimum inhibitory concentrations of chloramphenicol, florfenicol, trimethoprim/sulfadiazine and flumequine in seawater of bacteria associated with scallops (Pecten maximus)larvae. Aquaculture, 185:1-12
Tyrpenou A, Rigos G, Athanassopoulou F (2002) Determination of chloramphenicol residues in gilthead sea bream (Spams aurata L.) tissues by HPLC- PDA. Journal of Liquid Chromatography and Related Technologies, 25:655-663
Most read articles by the same author(s)